Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries

We are analyzing https://link.springer.com/chapter/10.1007/978-0-387-69080-3_23.

Title:
Androgen Receptor Coactivators and Prostate Cancer | SpringerLink
Description:
Among USA men, prostate cancer (PC) is the second most common cause of death from cancer. Thus, the etiology, prevention, and treatment of the disease are a major health concern. Development and differentiation of the prostate is androgen dependent and PC, too, is...
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

androgen, google, scholar, receptor, pubmed, cas, cancer, article, prostate, cell, biol, chapter, usa, chem, growth, res, mol, agoulnik, weigel, biology, steroid, privacy, cookies, content, information, publish, hormonal, nuclear, download, cells, src, activation, proliferation, springer, function, search, coactivators, treatment, major, tumor, factor, hormone, role, action, therapy, preview, domain, proc, natl, acad,

Topics {✒️}

month download article/chapter androgen-independent prostate cancers androgen-independent prostate cancer ligand-activated transcription factors hormone-activated transcription factor nh2-terminal interaction androgen-dependent proliferation prostate [epub ahead androgen receptor function steroid receptor coactivator-1 dominant-negative mutant androgen receptor coactivators epidermal growth factor early biochemical recurrence androgen receptor coactivator androgen receptor corepressor cell cycle genes androgen receptor action nuclear receptor coactivators prostate cancer cells chapter hormonal carcinogenesis privacy choices/manage cookies androgen receptor interact human androgen receptor androgen receptor corepressors androgen receptor transactivation androgen receptor activation cyclin d1 binding recurrent prostate cancer keratinocyte growth factor burd cj progesterone receptor action device instant download prostate carcinoma cells androgen ablation therapy nuclear domain residency li phd  & sara human prostate carcinoma actr/aib1/src-3 ligand binding domain androgen-repleted males national cancer institute androgen deprivation therapy nuclear targeting signals structure–function analysis gene expression analysis major circulating androgen expression level correlates higher affinity ligand download preview pdf

Schema {🗺️}

ScholarlyArticle:
      headline:Androgen Receptor Coactivators and Prostate Cancer
      pageEnd:255
      pageStart:245
      image:https://media.springernature.com/w153/springer-static/cover/book/978-0-387-69080-3.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Hormonal Carcinogenesis V
         isbn:
            978-0-387-69080-3
            978-0-387-69078-0
         type:Book
      publisher:
         name:Springer New York
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Irina U. Agoulnik
            affiliation:
            type:Person
            name:Nancy L. Weigel
            affiliation:
                  name:Baylor College of Medicne
                  address:
                     name:Dept. of Molecular and Cellular Biology, Baylor College of Medicne, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      keywords:Prostate Cancer, Androgen Receptor, LNCaP Cell, Steroid Receptor, DU145 Cell
      description:Among USA men, prostate cancer (PC) is the second most common cause of death from cancer. Thus, the etiology, prevention, and treatment of the disease are a major health concern. Development and differentiation of the prostate is androgen dependent and PC, too, is androgen dependent (1). Consequently, some form of androgen deprivation is the primary treatment for metastatic PC. Although effective initially in reducing tumor burden, the tumors become resistant to androgen deprivation and recur within a relatively short period of time. The actions of androgens are mediated by the androgen receptor (AR) a hormone-activated transcription factor, which belongs to the large nuclear receptor superfamily of ligand-activated transcription factors (2, 3). AR differs from many of the other receptors in that it has two natural endogenous ligands. Testosterone (T) (Fig. 1) is the major circulating androgen and is the major hormone in most tissues. T is produced in the testis and is converted to 5α-dihydrotestosterone (DHT) (Fig. 1) by the enzyme 5α-reductase in the prostate as well as in selected other tissues including skin. DHT is a higher affinity ligand and is functionally the most important androgen in the prostate. In addition, there are a number of androgen metabolites including DHEA and androstenediol, which have much lower affinities for AR. Although these androgens are not thought to play a major role in AR action in androgen-repleted males, they may activate the AR when levels of T and DHT are reduced as a result of androgen ablation therapy.
      datePublished:2008
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Hormonal Carcinogenesis V
      isbn:
         978-0-387-69080-3
         978-0-387-69078-0
Organization:
      name:Springer New York
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Baylor College of Medicne
      address:
         name:Dept. of Molecular and Cellular Biology, Baylor College of Medicne, Houston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Irina U. Agoulnik
      affiliation:
      name:Nancy L. Weigel
      affiliation:
            name:Baylor College of Medicne
            address:
               name:Dept. of Molecular and Cellular Biology, Baylor College of Medicne, Houston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Dept. of Molecular and Cellular Biology, Baylor College of Medicne, Houston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(151)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js

4.61s.